If a coronavirus vaccine arrives, can the world make enough?

Nature. 2020 Apr;580(7805):578-580. doi: 10.1038/d41586-020-01063-8.
No abstract available

Keywords: SARS-CoV-2; Vaccines.

MeSH terms

  • COVID-19
  • COVID-19 Vaccines
  • Child
  • Clinical Trials as Topic / economics
  • Coronavirus Infections / economics
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Developed Countries / economics
  • Drug Industry / economics
  • Health Care Rationing* / economics
  • Health Care Rationing* / organization & administration
  • Health Resources* / economics
  • Health Resources* / organization & administration
  • Hoarding / prevention & control
  • Humans
  • Immunization, Secondary
  • International Cooperation
  • Investments
  • Nicotiana / genetics
  • Nicotiana / metabolism
  • Nicotiana / virology
  • Pandemics / economics
  • Pandemics / prevention & control*
  • Pneumonia, Viral / economics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control*
  • Socioeconomic Factors*
  • Strategic Stockpile
  • Time Factors
  • Vaccines, Subunit / supply & distribution
  • Vaccines, Synthetic / supply & distribution
  • Viral Vaccines / adverse effects
  • Viral Vaccines / economics*
  • Viral Vaccines / supply & distribution*
  • World Health Organization

Substances

  • COVID-19 Vaccines
  • Vaccines, Subunit
  • Vaccines, Synthetic
  • Viral Vaccines